A tailored hydration protocol using electrolyte-enriched fluids improves VO₂ max, cognitive focus, and reduces muscle soreness in endurance athletes. This technology offers a personalized approach based on individual sweat composition for peak athletic output.
The personalized hydration protocol developed by DueNorth Biodev is designed to optimize athletic performance and recovery. By tailoring electrolyte-enriched fluids to individual sweat composition, athletes can experience improvements in VO₂ max, cognitive focus during gameplay, and reduced post-training muscle soreness. This solution targets endurance athletes seeking to enhance their performance through scientifically-backed hydration strategies.
Key features:
This personalized hydration protocol has reached Technology Readiness Level 6, having been validated in a controlled trial setting. It is ready for further real-world testing and commercial deployment.
DueNorth BioDev provides guidance and support for patients navigating cancer screening, diagnosis confirmation, and clinical trial options. The company focuses on addressing challenges in the healthcare system, such as the difficulty patients face in locating appropriate clinical trials outside of their own institutions and the high rate of cancer misdiagnosis. By providing information and resources, they aim to help patients better understand their screening results and identify potential treatment paths when standard options are unavailable or ineffective. Their services are designed to assist individuals who may feel unsupported or overwhelmed by complex medical language and fragmented clinical trial information. Through these offerings, DueNorth BioDev acts as a resource for those seeking greater clarity and proactive management of their cancer care journey, emphasizing the importance of timely and accurate diagnosis as well as access to promising new treatment opportunities.